Q4 2024 Allurion Technologies Inc Earnings Call Transcript
Key Points
- Allurion Technologies Inc (ALUR) reported a successful combination of their balloon program with low-dose GLP-1s, showing promising results in weight loss and muscle mass preservation.
- The company has a clear five-pillar plan for 2025, including a new commercial strategy, FDA approval efforts, and profitability goals for their ex-US business.
- Operating expenses decreased by 39% in the fourth quarter of 2024, indicating successful restructuring and reorganization efforts.
- Allurion Technologies Inc (ALUR) resumed sales in France after regulatory clearance, which is expected to contribute to future revenue growth.
- The company raised additional capital, providing a cash runway into 2026 and through expected FDA approval, strengthening their financial position.
- Fourth quarter revenue decreased to $5.6 million from $8.2 million in the same period in 2023, primarily due to the temporary suspension of sales in France and macroeconomic headwinds.
- Gross profit for the fourth quarter was negatively impacted, with a reduction to $2.5 million or 45% of revenue, compared to $6.4 million or 78% of revenue in 2023.
- The company recorded an adjustment for excess and obsolete inventory, affecting gross profit margins.
- Sales and marketing expenses, although reduced, still included $3.1 million of restructuring costs.
- The company anticipates a material contribution from France only in 2026, indicating a delayed impact on revenue from this market.
Hello, everyone, and welcome to Allurion fourth quarter earnings call. Please note that this call is being recorded. After the speaker's prepared remarks, there will be a question and answer session. (Operator Instructions)
Thank you.
Good morning, and thank you for joining us. Earlier today, Allurion Technologies Inc., Issued a press release announcing financial results for the quarter ended December 31, 2024, and provided a business update. You can access a copy of the announcement on the company's website at investors.allurion.com. With me on the call today is Shantanu Gaur, Founder and Chief Executive Officer.
Before we begin, I would like to inform you that comments mentioned on today's call contain forward-looking statements within the meeting of Federal Security Laws. Actual results may differ materially from those expressed or implied as a result of certain risks and uncertainties. These risks and uncertainties are described in detail in our Securities and
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
